Some experts believe, with proper precautions—and when other treatments have failed—that ketamine-assisted psychotherapy can ...

For the last several quarters, Gilead Sciences’ earnings calls have been colored by anticipation for the launch of the California drugmaker's long-acting HIV pre-exposure prophylaxis (PrEP) option. | ...

From hard-to-find mushrooms to unique coffee beans to certain delicacies, this list includes some of the world's rarest ...

A new way to deliver protective antibodies against COVID-19 was tested in a Phase I clinical trial. Instead of injecting ...

Scientists from the University of California have warned that some ingredient combinations may not be as healthy as they seem ...

There are two ways a fondue night goes wrong: the oil smokes and stings your eyes, or the meat turns out grey and dry. Both ...

Learn more about whether Alkermes plc or Arcus Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Nasus Pharma Ltd. (($NSRX)) announced an update on their ongoing clinical study. Study Overview: Nasus Pharma Ltd. is conducting a clinical study ...

In our study we were able to give up to four doses in some subjects ... Most side effects were limited to mild, temporary ...

Canadian robotics startup Cobionix has raised $4.1 million in strategic equity funding to accelerate the commercialization of ...

The stone foundation and large windows give it a sturdy, timeless quality – as if it ... with exacting standards for optimal marbling – that delicate network of intramuscular fat that melts during ...

Taken together, four proposals under consideration would make the landscape of overdose response more hostile toward people ...